- Report
- January 2024
- 165 Pages
Global
From €4588EUR$4,950USD£3,854GBP
- Report
- March 2024
- 181 Pages
Global
From €3651EUR$3,939USD£3,067GBP
- Report
- August 2024
- 149 Pages
Global
From €3614EUR$3,899USD£3,036GBP
- Report
- February 2024
- 114 Pages
Global
From €4403EUR$4,750USD£3,698GBP
- Report
- April 2023
- 76 Pages
Asia Pacific
From €4403EUR$4,750USD£3,698GBP
- Report
- April 2023
- 74 Pages
Europe
From €4403EUR$4,750USD£3,698GBP
- Report
- August 2022
- 108 Pages
Saudi Arabia
From €3105EUR$3,350USD£2,608GBP
- Report
- August 2022
- 84 Pages
Global
From €3500EUR$4,045USD£3,043GBP
- Report
- December 2023
- 204 Pages
Asia Pacific
From €2780EUR$2,999USD£2,335GBP
- Report
- December 2023
- 240 Pages
Latin America
From €2780EUR$2,999USD£2,335GBP
The Equine Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for horses. Vaccines are used to protect horses from a variety of diseases, including rabies, tetanus, West Nile virus, and equine influenza. Vaccines are typically administered by veterinarians or horse owners, and may be given as a single dose or as a series of doses.
Equine Vaccines are typically produced by pharmaceutical companies, and may be sold directly to veterinarians or horse owners, or through distributors. Vaccines may be available in a variety of forms, including injectable, intranasal, and oral.
The Equine Vaccine market is an important part of the Animal Pharmaceuticals industry, as it helps to protect horses from a variety of diseases. Vaccines are also important for the health of the horse industry, as they help to reduce the spread of disease and improve the overall health of horses.
Some companies in the Equine Vaccine market include Merck Animal Health, Boehringer Ingelheim, Zoetis, and Elanco. Show Less Read more